Quick Answer
Beta Bionics, Inc. reported Stockholders Equity of $287.61 million for fiscal year 2025.
Beta Bionics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $287.61M | +217.2% |
| 2024 | -$245.36M | -20.8% |
| 2023 | -$203.10M | -19.4% |
| 2022 | -$170.03M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $294.76M | +228.8% | -2.3% |
| June 30, 2025 | $301.63M | +236.4% | -3.9% |
| March 31, 2025 | $313.75M | +246.4% | +227.9% |
| December 31, 2024 | -$245.36M | -20.8% | -7.2% |
| September 30, 2024 | -$228.85M | — | -3.5% |
| June 30, 2024 | -$221.21M | — | -3.2% |
| March 31, 2024 | -$214.32M | — | -5.5% |
| December 31, 2023 | -$203.10M | — | — |
- Beta Bionics, Inc. showed an increase of +217.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, Beta Bionics, Inc.’s stockholders equity has grown by 269.1% (from -$170.03 million to $287.61 million).
- The most recent figure is from Beta Bionics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: